top of page

Perspectives in Breast Cancer Pathology

by Michael Lagios, MD

Please click on title to view complete text:

Contradictory Treatment Recommendations for Ductal Carcinoma in situ (DCIS).

Risk of DCIS Recurrence by Oncotype DCIS Technology - Some Concerns.

The Clinical Significance of immunohistochemically Detectable Epithelial Cells in Sentinel Lymph Node and Bone Marrow in Breast Cancer.

Factors Influencing the Accuracy of a Core Biopsy Diagnosis of Atypical Hyperplasia. A Perspective on a Frequent Pattern.

Tamoxifen as an Adjuvant Agent for Ductal Carcinoma In Situ (DCIS)

The Breast Cancer Consultation Service

Michael D. Lagios, MD • 415-789-0965

bottom of page